Precigen financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

프레시젠NASDAQ:PGEN · Nasdaq · Healthcare

$8.54+4.02%

2026-10-02 close

Precigen's published financial data is dated 2026-10-04. 2024 revenue was $4M. 2024 operating profit was −$135M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy